BRCA1 through Its E3 Ligase Activity Regulates the Transcription Factor Oct1 and Carbohydrate Metabolism

Area of Science:

• Molecular biology
• Cancer research
• Metabolic pathways

Background:

• The tumor suppressor BRCA1 plays a role in DNA damage response and other cellular processes.
• BRCA1 interacts with BARD1 to ubiquitylate targets, utilizing its N-terminal E3 ligase activity.
• The precise functions of BRCA1 beyond DNA repair are still being investigated.

Purpose of the Study:

• To investigate the role of BRCA1 in regulating cellular metabolism.
• To determine if BRCA1 influences the levels or activity of the transcription factor Oct1.
• To understand the implications of BRCA1-mediated Oct1 regulation in cancer progression.

Main Methods:

• Utilized CRISPR technology for Oct1 deletion in cell lines.
• Performed RNA sequencing (RNAseq) to analyze gene expression changes.
• Investigated protein ubiquitylation and degradation assays.
• Examined Oct1 protein levels in primary breast cancer specimens.

Main Results:

• BRCA1 promotes oxidative metabolism by degrading the transcription factor Oct1.
• BRCA1 E3 ubiquitin ligase mutations lead to a glycolytic shift and increased Oct1 levels.
• Oct1 deletion reverses the glycolytic phenotype and affects metabolic gene expression.
• BRCA1-mediated Oct1 ubiquitylation and degradation were confirmed, with specific lysine mutations conferring stability.
• Oct1 deletion inhibited tumor growth in soft agar and xenograft models.
• In clinical samples, high Oct1 levels correlated with tumor aggressiveness and low BRCA1 levels.

Conclusions:

• BRCA1 functions as an Oct1 ubiquitin ligase, catalyzing Oct1 degradation.
• This degradation promotes oxidative metabolism and suppresses tumorigenicity.
• BRCA1-mediated regulation of Oct1 is a critical mechanism in controlling cancer progression.